 | • レポートコード：MRC2-11QY02610 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗腫瘍薬のグローバル市場について調査・分析したレポートです。種類別（外科、化学療法、放射線、標的、免疫療法）市場規模、用途別（病院用、診療所用、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗腫瘍薬の競争状況、市場シェア ・世界の抗腫瘍薬市場：種類別市場規模 2015年-2020年（外科、化学療法、放射線、標的、免疫療法） ・世界の抗腫瘍薬市場：種類別市場規模予測 2021年-2026年（外科、化学療法、放射線、標的、免疫療法） ・世界の抗腫瘍薬市場：用途別市場規模 2015年-2020年（病院用、診療所用、家庭用、その他） ・世界の抗腫瘍薬市場：用途別市場規模予測 2021年-2026年（病院用、診療所用、家庭用、その他） ・北米の抗腫瘍薬市場分析：米国、カナダ ・ヨーロッパの抗腫瘍薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗腫瘍薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗腫瘍薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗腫瘍薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Novartis、Celgene ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor… It has been observed that cancer is second leading cause of deaths in Europe and North America. To treat these tumor growth, anti tumor drugs are considered as of one of the key therapy which has been accepted worldwide.
The market is concentrated in the North American region and together with Europe accounts for over 60% of the market share. The Asian and African economies possess a substantial growth opportunity owing to high cancer mortalities and bleak availability of effective drugs. Chinese and Japanese drug manufacturers dominate the Asian market with over 60% of the regional share.
Market Analysis and Insights: Global Anti-Tumor Drugs Market
The global Anti-Tumor Drugs market size is projected to reach US$ 98610 million by 2026, from US$ 94340 million in 2020, at a CAGR of 4.2%% during 2021-2026.
Global Anti-Tumor Drugs Scope and Market Size
Anti-Tumor Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Tumor Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Tumor Drugs market is segmented into
Surgical
Chemotherapy
Radiation
Targeted
Immunotherapy
Segment by Application, the Anti-Tumor Drugs market is segmented into
Hospital Use
Clinic Use
Household
Other
Regional and Country-level Analysis
The Anti-Tumor Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Tumor Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Tumor Drugs Market Share Analysis
Anti-Tumor Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Tumor Drugs business, the date to enter into the Anti-Tumor Drugs market, Anti-Tumor Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche
Novartis
Celgene
…
1 Study Coverage
1.1 Anti-Tumor Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Tumor Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Tumor Drugs Market Size Growth Rate by Type
1.4.2 Surgical
1.4.3 Chemotherapy
1.4.4 Radiation
1.4.5 Targeted
1.4.6 Immunotherapy
1.5 Market by Application
1.5.1 Global Anti-Tumor Drugs Market Size Growth Rate by Application
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Tumor Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Tumor Drugs Revenue 2015-2026
2.1.2 Global Anti-Tumor Drugs Sales 2015-2026
2.2 Global Anti-Tumor Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Tumor Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Tumor Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Tumor Drugs Competitor Landscape by Players
3.1 Anti-Tumor Drugs Sales by Manufacturers
3.1.1 Anti-Tumor Drugs Sales by Manufacturers (2015-2020)
3.1.2 Anti-Tumor Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Tumor Drugs Revenue by Manufacturers
3.2.1 Anti-Tumor Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Tumor Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Tumor Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Tumor Drugs Revenue in 2019
3.2.5 Global Anti-Tumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Tumor Drugs Price by Manufacturers
3.4 Anti-Tumor Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Tumor Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Tumor Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Tumor Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Tumor Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Tumor Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Tumor Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Tumor Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Tumor Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Tumor Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Tumor Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Tumor Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Tumor Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Tumor Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Tumor Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Tumor Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Tumor Drugs Price by Application (2015-2020)
5.2 Anti-Tumor Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Tumor Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Tumor Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Tumor Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Tumor Drugs by Country
6.1.1 North America Anti-Tumor Drugs Sales by Country
6.1.2 North America Anti-Tumor Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Tumor Drugs Market Facts & Figures by Type
6.3 North America Anti-Tumor Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Tumor Drugs by Country
7.1.1 Europe Anti-Tumor Drugs Sales by Country
7.1.2 Europe Anti-Tumor Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Tumor Drugs Market Facts & Figures by Type
7.3 Europe Anti-Tumor Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Tumor Drugs by Region
8.1.1 Asia Pacific Anti-Tumor Drugs Sales by Region
8.1.2 Asia Pacific Anti-Tumor Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Tumor Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anti-Tumor Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Tumor Drugs by Country
9.1.1 Latin America Anti-Tumor Drugs Sales by Country
9.1.2 Latin America Anti-Tumor Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Tumor Drugs Market Facts & Figures by Type
9.3 Central & South America Anti-Tumor Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Tumor Drugs by Country
10.1.1 Middle East and Africa Anti-Tumor Drugs Sales by Country
10.1.2 Middle East and Africa Anti-Tumor Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Tumor Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Tumor Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Anti-Tumor Drugs Products Offered
11.1.5 Roche Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Anti-Tumor Drugs Products Offered
11.2.5 Novartis Related Developments
11.3 Celgene
11.3.1 Celgene Corporation Information
11.3.2 Celgene Description and Business Overview
11.3.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Celgene Anti-Tumor Drugs Products Offered
11.3.5 Celgene Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Anti-Tumor Drugs Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Tumor Drugs Market Estimates and Projections by Region
12.1.1 Global Anti-Tumor Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Tumor Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Tumor Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Tumor Drugs Sales Forecast (2021-2026)
12.2.2 North America: Anti-Tumor Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Tumor Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Tumor Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Tumor Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Tumor Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Tumor Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Tumor Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Tumor Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Tumor Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Tumor Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Tumor Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Tumor Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Tumor Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Tumor Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Tumor Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Tumor Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Tumor Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Tumor Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Tumor Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Tumor Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-Tumor Drugs Market Segments
Table 2. Ranking of Global Top Anti-Tumor Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Tumor Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Surgical
Table 5. Major Manufacturers of Chemotherapy
Table 6. Major Manufacturers of Radiation
Table 7. Major Manufacturers of Targeted
Table 8. Major Manufacturers of Immunotherapy
Table 9. Global Anti-Tumor Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Anti-Tumor Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Anti-Tumor Drugs Sales by Regions 2015-2020 (K Units)
Table 12. Global Anti-Tumor Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Anti-Tumor Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Anti-Tumor Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Anti-Tumor Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Anti-Tumor Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Anti-Tumor Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Tumor Drugs as of 2019)
Table 18. Anti-Tumor Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Anti-Tumor Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Anti-Tumor Drugs Price (2015-2020) (USD/Unit)
Table 21. Anti-Tumor Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anti-Tumor Drugs Product Type
Table 23. Date of International Manufacturers Enter into Anti-Tumor Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-Tumor Drugs Sales by Type (2015-2020) (K Units)
Table 26. Global Anti-Tumor Drugs Sales Share by Type (2015-2020)
Table 27. Global Anti-Tumor Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Anti-Tumor Drugs Revenue Share by Type (2015-2020)
Table 29. Anti-Tumor Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Anti-Tumor Drugs Sales by Application (2015-2020) (K Units)
Table 31. Global Anti-Tumor Drugs Sales Share by Application (2015-2020)
Table 32. North America Anti-Tumor Drugs Sales by Country (2015-2020) (K Units)
Table 33. North America Anti-Tumor Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Anti-Tumor Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Anti-Tumor Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Anti-Tumor Drugs Sales by Type (2015-2020) (K Units)
Table 37. North America Anti-Tumor Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Anti-Tumor Drugs Sales by Application (2015-2020) (K Units)
Table 39. North America Anti-Tumor Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Anti-Tumor Drugs Sales by Country (2015-2020) (K Units)
Table 41. Europe Anti-Tumor Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Anti-Tumor Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Anti-Tumor Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Anti-Tumor Drugs Sales by Type (2015-2020) (K Units)
Table 45. Europe Anti-Tumor Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Anti-Tumor Drugs Sales by Application (2015-2020) (K Units)
Table 47. Europe Anti-Tumor Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Anti-Tumor Drugs Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Anti-Tumor Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-Tumor Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Anti-Tumor Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Anti-Tumor Drugs Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Anti-Tumor Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Anti-Tumor Drugs Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Anti-Tumor Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Anti-Tumor Drugs Sales by Country (2015-2020) (K Units)
Table 57. Latin America Anti-Tumor Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Anti-Tumor Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Anti-Tumor Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Anti-Tumor Drugs Sales by Type (2015-2020) (K Units)
Table 61. Latin America Anti-Tumor Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Anti-Tumor Drugs Sales by Application (2015-2020) (K Units)
Table 63. Latin America Anti-Tumor Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Anti-Tumor Drugs Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Anti-Tumor Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-Tumor Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Anti-Tumor Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anti-Tumor Drugs Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Anti-Tumor Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Anti-Tumor Drugs Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Anti-Tumor Drugs Sales Market Share by Application (2015-2020)
Table 72. Roche Corporation Information
Table 73. Roche Description and Major Businesses
Table 74. Roche Anti-Tumor Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Roche Product
Table 76. Roche Recent Development
Table 77. Novartis Corporation Information
Table 78. Novartis Description and Major Businesses
Table 79. Novartis Anti-Tumor Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Novartis Product
Table 81. Novartis Recent Development
Table 82. Celgene Corporation Information
Table 83. Celgene Description and Major Businesses
Table 84. Celgene Anti-Tumor Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Celgene Product
Table 86. Celgene Recent Development
Table 87. Global Anti-Tumor Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 88. Global Anti-Tumor Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 89. Global Anti-Tumor Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 90. Global Anti-Tumor Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 91. North America: Anti-Tumor Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 92. North America: Anti-Tumor Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Europe: Anti-Tumor Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 94. Europe: Anti-Tumor Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Asia Pacific: Anti-Tumor Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 96. Asia Pacific: Anti-Tumor Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 97. Latin America: Anti-Tumor Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 98. Latin America: Anti-Tumor Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Middle East and Africa: Anti-Tumor Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 100. Middle East and Africa: Anti-Tumor Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key Anti-Tumor Drugs Players
Table 105. Anti-Tumor Drugs Customers List
Table 106. Anti-Tumor Drugs Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Tumor Drugs Product Picture
Figure 2. Global Anti-Tumor Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Surgical Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Radiation Product Picture
Figure 6. Targeted Product Picture
Figure 7. Immunotherapy Product Picture
Figure 8. Global Anti-Tumor Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Use
Figure 10. Clinic Use
Figure 11. Household
Figure 12. Other
Figure 13. Anti-Tumor Drugs Report Years Considered
Figure 14. Global Anti-Tumor Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Anti-Tumor Drugs Sales 2015-2026 (K Units)
Figure 16. Global Anti-Tumor Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Anti-Tumor Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Anti-Tumor Drugs Sales Market Share by Region in 2019
Figure 19. Global Anti-Tumor Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Anti-Tumor Drugs Revenue Market Share by Region in 2019
Figure 21. Global Anti-Tumor Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Anti-Tumor Drugs Revenue in 2019
Figure 23. Anti-Tumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Anti-Tumor Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Anti-Tumor Drugs Sales Market Share by Type in 2019
Figure 26. Global Anti-Tumor Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Anti-Tumor Drugs Revenue Market Share by Type in 2019
Figure 28. Global Anti-Tumor Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Anti-Tumor Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Anti-Tumor Drugs Sales Market Share by Application in 2019
Figure 31. Global Anti-Tumor Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Anti-Tumor Drugs Revenue Market Share by Application in 2019
Figure 33. North America Anti-Tumor Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Anti-Tumor Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Anti-Tumor Drugs Sales Market Share by Country in 2019
Figure 36. North America Anti-Tumor Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Anti-Tumor Drugs Market Share by Type in 2019
Figure 42. North America Anti-Tumor Drugs Market Share by Application in 2019
Figure 43. Europe Anti-Tumor Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Anti-Tumor Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Anti-Tumor Drugs Sales Market Share by Country in 2019
Figure 46. Europe Anti-Tumor Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Anti-Tumor Drugs Market Share by Type in 2019
Figure 58. Europe Anti-Tumor Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Anti-Tumor Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Anti-Tumor Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Anti-Tumor Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Anti-Tumor Drugs Revenue Market Share by Region in 2019
Figure 63. China Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Anti-Tumor Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Anti-Tumor Drugs Market Share by Application in 2019
Figure 87. Latin America Anti-Tumor Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Anti-Tumor Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Anti-Tumor Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Anti-Tumor Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Anti-Tumor Drugs Market Share by Type in 2019
Figure 98. Latin America Anti-Tumor Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Anti-Tumor Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Anti-Tumor Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Anti-Tumor Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Anti-Tumor Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Anti-Tumor Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Anti-Tumor Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Anti-Tumor Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Anti-Tumor Drugs Market Share by Application in 2019
Figure 111. North America Anti-Tumor Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Anti-Tumor Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Anti-Tumor Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Anti-Tumor Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Anti-Tumor Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Anti-Tumor Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Anti-Tumor Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Anti-Tumor Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Anti-Tumor Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Anti-Tumor Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 止瀉薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Diarrheal Drugs Market The global Anti Diarrheal Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Diarrheal Drugs Scope and Market Size Anti Diarrheal Drugs market is…
- 抗ニキビ薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Acne Drugs Market The global Anti Acne Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Acne Drugs Scope and Market Size Anti Acne Drugs market is segmented by Type, …
- 抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…